Related Experiment Video
Updated: May 23, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Comprehensive care in hemophilia
1National Hemophilia Center, Banco de Sangre Metropolitano, Caracas, Venezuela. arletteruizsaez@gmail.com
Hematology (Amsterdam, Netherlands)
|April 18, 2012
Summary
Comprehensive hemophilia care requires more than just factor concentrates. It involves accurate diagnosis, specialized multidisciplinary teams, and dedicated Hemophilia Treatment Centers for improved patient quality of life.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Hemophilia is a chronic, inherited X-linked bleeding disorder necessitating lifelong medical attention.
- Treatment is complex and expensive, largely due to the cost of factor concentrates for replacement therapy.
- Effective hemophilia management extends beyond treatment to include accurate diagnosis and specialized, comprehensive care.
Purpose of the Study:
- To define the essential components of comprehensive hemophilia care.
- To highlight the importance of specialized Hemophilia Treatment Centers.
- To emphasize the role of multidisciplinary teams and patient/family involvement.
Main Methods:
- Review of current hemophilia management strategies.
- Definition of comprehensive care principles.
- Analysis of the benefits of specialized treatment centers.
Main Results:
- Comprehensive care integrates medical and psychological support for patients and families.
- Specialized Hemophilia Treatment Centers are crucial for coordinated, multidisciplinary care, preferably led by hematologists.
- Benefits of hemophilia centers are evident even in developing nations through resource reorganization and training.
Conclusions:
- Establishing dedicated Hemophilia Treatment Centers improves patient outcomes and quality of life.
- Multidisciplinary teams, patient/family engagement, and government support are vital for national comprehensive care programs.
- Reorganization of resources, education, and training are key to achieving better hemophilia management globally.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...